Healio

Simlandi launches in U.S. as third interchangeable Humira biosimilar

Please provide your email address to receive an email when new articles are posted on . Simlandi (adalimumab-ryvk) hit the market as first interchangeable, citrate-free Humira biosimilar in a ...
Monthly Prescribing Reference

FDA Approves Simlandi, a Citrate-Free, High-Concentration, Interchangeable Biosimilar to Humira

Credit: Teva. Simlandi is an interchangeable biosimilar and can be substituted for the reference product without requiring a prescription change. The Food and Drug Administration (FDA) has approved ...
WWLP

Alvotech and Teva Announce U.S. Approval of SIMLANDI® (adalimumab-ryvk) injection, the first interchangeable high-concentration, citrate-free biosimilar to Humira®

SIMLANDI is the first high-concentration, citrate-free biosimilar to Humira that has been granted an interchangeability status by the FDA, and will qualify for interchangeable exclusivity for the 40mg ...
Healio

Boehringer Ingelheim, Quallent partner to expand Humira biosimilar access

Please provide your email address to receive an email when new articles are posted on . Quallent will offer both low- and high-concentration citrate-free adalimumab-adbm. The existing biosimilar ...